Paper75815
Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus.
Gepts W and 1 other. Diabetes, 1978. Cited by 202 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Papers, record 75815. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/75815
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| Islets of Langerhans | Major topic |
| Adolescent | |
| Adult | |
| Cell Count | |
| Child | |
| Child, Preschool | |
| Female | |
| Histocytochemistry | |
| Humans | |
| Infant | |
| Male | |
| Staining and Labeling |
Source PubMed
Cited by76
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 202 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,327,161 | AI-guided analysis of human pancreatic islet sociology reveals distinct cell compositional changes in type 1 diabetes. | bioRxiv | 2026 | https://conductscience.org/library/papers/42327161 | PubMed |
| 39,337,311 | Adropin Is Expressed in Pancreatic Islet Cells and Reduces Glucagon Release in Diabetes Mellitus. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337311 | PubMed |
| 39,283,482 | β-Cell Heterogeneity and Plasticity. | Adv Anat Embryol Cell Biol | 2024 | https://conductscience.org/library/papers/39283482 | PubMed |
| 38,922,355 | Loss of insulin-expressing extra-islet cells in type 1 diabetes is accompanied with increased number of glucagon-expressing extra-islet cells. | Virchows Arch | 2025 | https://conductscience.org/library/papers/38922355 | PubMed |
| 36,346,618 | An Early Islet Transcriptional Signature Is Associated With Local Inflammation in Autoimmune Diabetes. | Diabetes | 2023 | https://conductscience.org/library/papers/36346618 | PubMed |
| 34,115,115 | A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance. | J Exp Med | 2021 | https://conductscience.org/library/papers/34115115 | PubMed |
| 32,802,890 | Two to Tango: Dialogue between Adaptive and Innate Immunity in Type 1 Diabetes. | J Diabetes Res | 2020 | https://conductscience.org/library/papers/32802890 | PubMed |
| 32,324,170 | Pancreas tissue slices from organ donors enable in situ analysis of type 1 diabetes pathogenesis. | JCI Insight | 2020 | https://conductscience.org/library/papers/32324170 | PubMed |
| 31,839,487 | New Frontiers in the Treatment of Type 1 Diabetes. | Cell Metab | 2020 | https://conductscience.org/library/papers/31839487 | PubMed |
| 30,767,048 | Beta cells in type 1 diabetes: mass and function; sleeping or dead? | Diabetologia | 2019 | https://conductscience.org/library/papers/30767048 | PubMed |
| 30,293,191 | Pancreas Pathology During the Natural History of Type 1 Diabetes. | Curr Diab Rep | 2018 | https://conductscience.org/library/papers/30293191 | PubMed |
| 30,073,765 | Persistent elevations in circulating INS DNA among subjects with longstanding type 1 diabetes. | Diabetes Obes Metab | 2019 | https://conductscience.org/library/papers/30073765 | PubMed |
| 28,959,234 | Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment. | Front Endocrinol (Lausanne) | 2017 | https://conductscience.org/library/papers/28959234 | PubMed |
| 28,951,820 | Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis. | Mol Metab | 2017 | https://conductscience.org/library/papers/28951820 | PubMed |
| 28,763,258 | Cyclin D2 is sufficient to drive β cell self-renewal and regeneration. | Cell Cycle | 2017 | https://conductscience.org/library/papers/28763258 | PubMed |
| 28,323,930 | β Cells Persist in T1D Pancreata Without Evidence of Ongoing β-Cell Turnover or Neogenesis. | J Clin Endocrinol Metab | 2017 | https://conductscience.org/library/papers/28323930 | PubMed |
| 28,223,284 | Mafa Enables Pdx1 to Effectively Convert Pancreatic Islet Progenitors and Committed Islet α-Cells Into β-Cells In Vivo. | Diabetes | 2017 | https://conductscience.org/library/papers/28223284 | PubMed |
| 28,099,204 | Narrowing in on the anti-β cell-specific T cells: looking 'where the action is'. | Curr Opin Endocrinol Diabetes Obes | 2017 | https://conductscience.org/library/papers/28099204 | PubMed |
| 27,591,120 | Cellular senescence: Implications for metabolic disease. | Mol Cell Endocrinol | 2017 | https://conductscience.org/library/papers/27591120 | PubMed |
| 26,013,143 | miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development. | J Mol Med (Berl) | 2015 | https://conductscience.org/library/papers/26013143 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/75815
GET https://conductscience.org/api/papers/v1/75815/cited_by?page=2